XENT

Intersect ENT, Inc

Delisted

XENT was delisted on the 12th of May, 2022.

120 hedge funds and large institutions have $776M invested in Intersect ENT, Inc in 2019 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 42 increasing their positions, 40 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
120
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$22.3M
Puts
$2.95M
Net Calls
Net Calls Change

Top Buyers

1 +$9.1M
2 +$6.71M
3 +$6.22M
4
Jennison Associates
Jennison Associates
New York
+$5.8M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$5.53M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$69.6M
2
$66M
3
$63.2M
4
$40.4M
5
$39M
6
$37M
7
$29.9M
8
$29M
9
$28.6M
10
$28.1M
11
$20.4M
12
$20.2M
13
$19.9M
14
$18.2M
15
$17.8M
16
$17M
17
$16.4M
18
$15.7M
19
$14.2M
20
$13M
21
$12.5M
22
$11.5M
23
$10.5M
24
$10.4M
25
$9.89M